- Citations, last 5 years
- 13.8k
- Works, last 5 years
- 2 014
- h-index
- 580
- Scientists listed
- 246
- Grants since 2016
- 630
Grants received
2016–2021 · research · R01
Targeting telomerase for melanoma therapeutics
Emmanuel Skordalakes · The Wistar Institute · funded by National Institutes of Health
2016–2021 · cooperative agreement · UM1
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
Luis J Montaner · The Wistar Institute · funded by National Institutes of Health
2016–2021 · research · R01
Extracellular DNA in regulation of multiple myeloma
Yulia Nefedova · The Wistar Institute · funded by National Institutes of Health
2016–2018 · career development · K99
Histone modifications regulating phenotype plasticity: Role of non-canonical Wnt signaling
Marie Ruth Webster · The Wistar Institute · funded by National Institutes of Health
2016–2026 · research · R50
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level
Andrew V Kossenkov · The Wistar Institute · funded by National Institutes of Health
2016–2021 · cooperative agreement · U01
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer
Qin Liu · The Wistar Institute · funded by National Institutes of Health
2016–2018 · research · R21
Mechanisms of Resistance in HIV-1 Exposed Sero-negative IV-drug Users: Induction of IFN-mediated Factors and S100 Proteins as Determinants of NK Cell-Mediated Clearance and Low CD4+ T Cell Infectivity
Costin Tomescu · The Wistar Institute · funded by National Institutes of Health
2016–2022 · cooperative agreement · U01
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer
Qin Liu · The Wistar Institute · funded by National Institutes of Health
2016–2021 · research · R50
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level
Andrew V Kossenkov · The Wistar Institute · funded by National Institutes of Health
2016–2021 · research · R01
Targeting telomerase for melanoma therapeutics
Emmanuel Skordalakes · The Wistar Institute · funded by National Institutes of Health
2016–2021 · research · R50
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level
Andrew V Kossenkov · The Wistar Institute · funded by National Institutes of Health
2016–2021 · cooperative agreement · UM1
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
Luis J Montaner · The Wistar Institute · funded by National Institutes of Health
2016–2021 · research · R01
Extracellular DNA in regulation of multiple myeloma
Yulia Nefedova · The Wistar Institute · funded by National Institutes of Health
2016–2019 · research · R21
Mechanisms of Resistance in HIV-1 Exposed Sero-negative IV-drug Users: Induction of IFN-mediated Factors and S100 Proteins as Determinants of NK Cell-Mediated Clearance and Low CD4+ T Cell Infectivity
Costin Tomescu · The Wistar Institute · funded by National Institutes of Health
2016–2023 · cooperative agreement · UM1
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
Luis J Montaner · The Wistar Institute · funded by National Institutes of Health
2016–2018 · research · R21
Regulation of multiple myeloma by S100A9 protein
Yulia Nefedova · The Wistar Institute · funded by National Institutes of Health
2016–2023 · research · Global Health
Wistar Institute of Anatomy & Biology - to develop a clinical trial candidate against Zika virus infection
The Wistar Institute · funded by Bill and Melinda Gates Foundation
2016–2021 · research · R01
Extracellular DNA in regulation of multiple myeloma
Yulia Nefedova · The Wistar Institute · funded by National Institutes of Health
2016–2021 · research · R50
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level
Andrew V Kossenkov · The Wistar Institute · funded by National Institutes of Health
2016–2026 · research · R50
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level
Andrew V Kossenkov · The Wistar Institute · funded by National Institutes of Health
2016–2021 · research · R50
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level
Andrew V Kossenkov · The Wistar Institute · funded by National Institutes of Health
2016–2021 · cooperative agreement · U01
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer
Qin Liu · The Wistar Institute · funded by National Institutes of Health
2016–2019 · career development · K99
Histone modifications regulating phenotype plasticity: Role of non-canonical Wnt signaling
Marie Ruth Webster · The Wistar Institute · funded by National Institutes of Health
2016–2021 · research · R01
Targeting telomerase for melanoma therapeutics
Emmanuel Skordalakes · The Wistar Institute · funded by National Institutes of Health
2016–2026 · research · R50
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level
Andrew V Kossenkov · The Wistar Institute · funded by National Institutes of Health
2016–2023 · cooperative agreement · U01
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer
Qin Liu · The Wistar Institute · funded by National Institutes of Health
2016–2018 · research · R21
Development of circulating biomarker for lung cancer
Louise C. Showe · The Wistar Institute · funded by National Institutes of Health
2016–2022 · research · R01
Extracellular DNA in regulation of multiple myeloma
Yulia Nefedova · The Wistar Institute · funded by National Institutes of Health
2016–2020 · grant · PRCRP
Understanding the Immune Biology of Checkpoint Inhibitors to Develop New Strategies for Therapy
Meenhard Herlyn · The Wistar Institute · funded by Congressionally Directed Medical Research Programs
2016–2021 · research · R50
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level
Andrew V Kossenkov · The Wistar Institute · funded by National Institutes of Health
2016–2021 · research · R01
Extracellular DNA in regulation of multiple myeloma
Yulia Nefedova · The Wistar Institute · funded by National Institutes of Health
2016–2021 · cooperative agreement · U01
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer
Qin Liu · The Wistar Institute · funded by National Institutes of Health
2016–2021 · cooperative agreement · UM1
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
Luis J Montaner · The Wistar Institute · funded by National Institutes of Health
2016–2019 · grant · PRCRP
Myeloid-Derived Suppressor Cells in Checkpoint Protein Inhibition for Melanoma
Chih-Chi Hu · The Wistar Institute · funded by Congressionally Directed Medical Research Programs
2016–2018 · research · R21
Development of circulating biomarker for lung cancer
Qihong Huang · The Wistar Institute · funded by National Institutes of Health
2016–2018 · research · R21
Regulation of multiple myeloma by S100A9 protein
Yulia Nefedova · The Wistar Institute · funded by National Institutes of Health
2016–2026 · research · R50
Integrative Approach to Comprehensive Analysis of High Throughput Data on a Cancer Center Level
Andrew V Kossenkov · The Wistar Institute · funded by National Institutes of Health
2016–2021 · research · R01
Targeting telomerase for melanoma therapeutics
Emmanuel Skordalakes · The Wistar Institute · funded by National Institutes of Health
2016–2019 · grant · PRCRP
Myeloid-Derived Suppressor Cells in Checkpoint Protein Inhibition for Melanoma
Dmitry Gabrilovich · The Wistar Institute · funded by Congressionally Directed Medical Research Programs
2016–2021 · cooperative agreement · UM1
BEAT-HIV: Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy
Luis J Montaner · The Wistar Institute · funded by National Institutes of Health